Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Settles Lawsuit, Signs Licensing Deal with Navigenics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has reached a settlement with direct-to-consumer genetic testing firm Navigenics and subsequently reached a licensing agreement for a patent related to methods of analyzing non-coding DNA sequences.

The Australian firm had sued Navigenics in May as part of a lawsuit which accused 10 companies of infringing on US Patent No. 5,612,179 titled, "Intron Sequence Analysis Method for Detection of Adjacent Locus Alleles as Haplotypes."

Along with Navigenics, other defendants in the case included Agilent Technologies; Bristol-Myers Squibb; Eurofins STA Laboratories; GlaxoSmithKline; Hologic; Merial; Neogen; Pfizer; and 454 Life Sciences.

Navigenics is the first party from the lawsuit to settle, Genetic Technologies said.

"To have a counterparty settle within the first month of filing the suit is very encouraging and speaks volumes, not only to the strength of the patents, but also the caliber of the assertion process," Paul MacLeman, CEO of Genetic Technologies, said in a statement.

Financial and other terms of the settlement as well as the licensing deal with Navigenics were not disclosed.

In April, Genetic Technologies concluded another lawsuit filed in February 2010 against a number of US companies alleging infringement of the '179 patent.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.